ArticleHealthcare technology letters
A Hybrid Ensemble Approach for Early-Stage Diabetes Detection.
Article in Healthcare technology letters. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Hybrid Ensemble Approach for Early-Stage Diabetes Detection.Healthcare technology lettersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes has become a critical global health concern, particularly in regions where access to diagnostic facilities is limited. In this work, we propose a hybrid framework that combines extreme gradient boosting (XGBoost) and deep neural networks (DNNs) for early-stage diabetes detection, using soft voting to generate the final ensemble predictions. The proposed framework was evaluated on two datasets: the widely used Diabetes UCI dataset and a newly collected dataset from Nepal. The ensemble method achieved 99% accuracy (ACC) with an area under the curve (AUC) of 1.00 on the Diabetes UCI dataset, and 91% ACC with a 0.96 AUC on the Nepal diabetes dataset, demonstrating its strong generalisability across distinct populations. Compared to individual models, the hybrid approach offered increased stability and a lower rate of false negatives, which is particularly important in clinical contexts. These findings highlight the potential of hybrid machine learning-deep learning models as cost-effective, scalable and generalisable decision-support tools for diabetes risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.